Name: Staphylococcus epidermidis Fussel
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 14529

Type strain:

Species: Staphylococcus epidermidis

Strain Designation: Fussel

Culture col. no.: DSM 20044, ATCC 14990, CCM 2124, WDCM 00132, JCM 2414, CCUG 18000, CCUG 39508, CECT 232, CIP 81.55, IAM 12013, LMG 10474, NBRC 100865, NBRC 100911, NCIMB 12721, NCTC 11047

Strain history: Y. Kosako <-- R. Sakazaki <-- ATCC 14990 <-- AMIF strain Fussel <-- R. Deibel.

NCBI tax ID(s): 1236978 (strain), 1282 (species)

Other strains from Staphylococcus epidermidis

Section

Staphylococcus epidermidis Fussel is a mesophilic human pathogen that was isolated from nose.

human pathogen
mesophilic
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	07-12-2022 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacillota*
	Class	*Bacilli*
	Order	*Caryophanales*
	Family	*Staphylococcaceae*
	Genus	*Staphylococcus*
	Species	**Staphylococcus epidermidis**
	Full Scientific Name (PNU)	Staphylococcus epidermidis (Winslow and Winslow 1908) Evans 1916 (Approved Lists 1980)

Synonym

"Albococcus epidermidis"

Information on morphological and physiological properties Morphology

[Ref.: #69480]

Gram stain

positive Confidence in %100

[Ref.: #8450]	Type of hemolysis	gamma
[Ref.: #8450]	Incubation period	1-2 days

Information on culture and growth conditions Culture and growth conditions

[Ref.: #8450]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #8450]

Culture medium growth

[Ref.: #8450]

Culture medium link

Medium recipe provided by DSMZ

[Ref.: #8450]

Culture medium composition

expand / minimize

[Ref.: #8450]

Culture medium

TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)

[Ref.: #8450]

Culture medium growth

[Ref.: #8450]

Culture medium link

Medium recipe provided by DSMZ

[Ref.: #8450]

Culture medium composition

expand / minimize

[Ref.: #41796]

Culture medium

MEDIUM 72- for trypto casein soja agar

[Ref.: #41796]

Culture medium growth

[Ref.: #41796]

Culture medium composition

expand / minimize

		Temperature
[Ref.: #8450]	growth	37 °C
[Ref.: #41796]	growth	37 °C
[Ref.: #67770]	growth	37 °C

[Ref.: #8450]	Temperature range	mesophilic
[Ref.: #41796]	Temperature range	mesophilic
[Ref.: #67770]	Temperature range	mesophilic

Information on physiology and metabolism Physiology and metabolism

Note that the displayed test results represent raw data and therefore may deviate!

Antibiotic susceptibility testing

Test 1

Test 2

Test 3

Test 4

Test 5

Test 6

Test 7

Test 8

Test 9

Test 10

Reference

[Ref.: #8450]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
30
38
32
34-36
30
40
38
36
resistant0
>50
10-12
34
32
30
22
38
38-40
32
36
8
20
30-32
16-18
14
30
30
20
32
40
50
38
40
resistant0
32
18
36

[Ref.: #8450]
Mueller-Hinton Agar
37

aerob
yes
Inhibition zone diameter in mm
30
38
32
34-36
30
40
38
36
resistant0
>50
10-12
34
32
30
22
38
38-40
32
36
8
20
30-32
16-18
14
30
30
20
32
40
50
38
40
resistant0
32
18
36

[Ref.: #8450]
M 92
37

aerob
yes
Inhibition zone diameter in mm
32
38
32
38
32
40
40
36
resistant0
>50
12
38
32
30
22
38-40
38-40
32
34-36
8
20
32
20
12
32
28
20
32
42
50
38
40-42
resistant0
34
20
38

[Ref.: #8450]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
26
38
26-28
32
26-28
40
34
34-36
resistant0
>50
12
34
30
30
20
36-38
36
32
32
10
18-20
28-30
16-18
12-14
30
26
20
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #8450]
Mueller-Hinton Agar
37


yes
Inhibition zone diameter in mm
14
28
12
14-16
18
28
24
28
resistant0
40
6
16
20-22
16-18
14-16
22
16-18
24-26
28
resistant0
10-12
18
10-12
8-10
20
18-20
12
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.
n.d.

[Ref.: #8450]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
32
42
32-34
40
34
46
40-42
40-42
resistant0
>50
10-12
30
32
32
32
34
34-36
34
40
18-20
20
32
16
14-16
32
30
18
36
38
50
38
38-40
resistant0
34-36
22
40

[Ref.: #8450]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
30
40
32
38
30-32
42
38-40
36
resistant0
>50
12-14
38-40
32
30-32
24
38-40
36
34
36
10
20-22
32-34
20-22
14
46
28
20
32-34
42
48-50
38
38-40
resistant0
36-38
20-22
36-38

[Ref.: #8450]
Mueller-Hinton Agar
37
1
aerob
yes
Inhibition zone diameter in mm
24
36
28
30
26-28
36
32
34
resistant0
>50
10
32
28-30
26-28
20
32-34
32-34
30
32-34
resistant0
16-18
30
16-18
10
26
24
20
32-34
38
>50
34
34-36
resistant0
32
18
34

[Ref.: #8450]
Mueller-Hinton Agar



yes
Inhibition zone diameter in mm
30
38
30-32
34
28-30
38-40
36-38
34
resistant0
>50
12
32
28-30
30
22
34
34
30-32
34
10
18
32
16
12
30
28
18-20
32
40
46-48
36
36
resistant0
32
18
34

[Ref.: #8450]
M 92
37

aerob
yes
Inhibition zone diameter in mm
32
38
32
38
32
40
40
36
resistant0
>50
12
38
32
30
22
38-40
38-40
32
34-36
8
20
32
20
12
32
28
20
32
42
50
38
40-42
resistant0
34
20
38

Only first 15 entries are displayed. Click here to see all.

[Ref.: #69481]	Ability of spore formation	no Confidence in %97
[Ref.: #69480]	Ability of spore formation	no Confidence in %99.392

[Ref.: #8450]	Murein short key	A11.03
[Ref.: #8450]	Murein types	A3alpha L-Lys-Gly₂_-₄-L-Ser₁_-₂-Gly

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68375]	arabinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68378]	arginine ChEBI	+	hydrolysis	* from API STA, API ID32STA
[Ref.: #68378]	D-fructose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	D-fructose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68378]	D-glucose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	D-glucose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #68378]	D-mannitol ChEBI	-	builds acid from	* from API STA
[Ref.: #68375]	D-mannitol ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68378]	D-mannose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	D-ribose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #68378]	D-xylose ChEBI	-	builds acid from	* from API STA
[Ref.: #68375]	esculin ChEBI	-	hydrolysis	* from API ID32STA
[Ref.: #22946]	fructose ChEBI	+	growth
[Ref.: #68378]	lactose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	lactose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #22946]	maltose ChEBI	+	growth
[Ref.: #68378]	maltose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	maltose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #22946]	mannose ChEBI	+/-	growth
[Ref.: #68378]	melibiose ChEBI	-	builds acid from	* from API STA
[Ref.: #68378]	methyl alpha-D-glucopyranoside ChEBI	-	builds acid from	* from API STA
[Ref.: #68378]	nitrate ChEBI	+	reduction	* from API STA, API ID32STA
[Ref.: #68378]	raffinose ChEBI	-	builds acid from	* from API STA
[Ref.: #68375]	raffinose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #22946]	ribose ChEBI	+	growth
[Ref.: #22946]	sucrose ChEBI	+	growth
[Ref.: #68378]	sucrose ChEBI	+	builds acid from	* from API STA
[Ref.: #68375]	sucrose ChEBI	+	fermentation	* from API ID32STA
[Ref.: #22946]	trehalose ChEBI	-	growth
[Ref.: #68378]	trehalose ChEBI	-	builds acid from	* from API STA
[Ref.: #68375]	trehalose ChEBI	-	fermentation	* from API ID32STA
[Ref.: #22946]	turanose ChEBI	+/-	growth
[Ref.: #68378]	urea ChEBI	+	hydrolysis	* from API STA, API ID32STA
[Ref.: #68378]	xylitol ChEBI	-	builds acid from	* from API STA
	Only first 10 entries are displayed. Click here to see all.

	Metabolite production	Metabolite
[Ref.: #68378]		acetoin ChEBI	* from API STA

	Physiological tests	Metabolite	Voges-Proskauer-test
[Ref.: #68378]		acetoin ChEBI	+	* from API STA

	Enzyme	Enzyme activity	EC number
[Ref.: #68378]	alkaline phosphatase	+	3.1.3.1	* from API STA
[Ref.: #68378]	arginine dihydrolase	+	3.5.3.6	* from API STA, API ID32STA
[Ref.: #68375]	beta-galactosidase	-	3.2.1.23	* from API ID32STA
[Ref.: #68375]	beta-glucosidase	-	3.2.1.21	* from API ID32STA
[Ref.: #68375]	beta-glucuronidase	-	3.2.1.31	* from API ID32STA
[Ref.: #8450]	catalase	+	1.11.1.6
[Ref.: #8450]	cytochrome-c oxidase	-	1.9.3.1
[Ref.: #68375]	L-arginine arylamidase	-		* from API ID32STA
[Ref.: #68375]	pyrrolidonyl arylamidase	-	3.4.19.3	* from API ID32STA
[Ref.: #68378]	urease	+	3.5.1.5	* from API STA, API ID32STA

API® ID32STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	Ornithine decarboxylaseODC	Esculin hydrolysisESC	Fermentation of D-glucoseGLU	Fermentation of D-fructoseFRU	Fermentation of D-mannoseMNE	Fermentation of maltoseMAL	Fermentation of lactoseLAC	Fermentation of trehaloseTRE	Fermentation of D-mannitolMAN	Fermentation of raffinoseRAF	Fermentation of D-riboseRIB	Fermentation of cellobioseCEL	Reduction of nitrateNIT	Acetoin production (Voges Proskauer test)VP	beta-Galactosidasebeta GAL	L-arginine arylamidaseArgA	Alkaline phosphatasePAL	Pyrrolidonyl arylamidasePyrA	Novobiocin resistanceNOVO	Fermentation of sucroseSAC	Fermentation of N-acetyl-glucosamineNAG	Fermentation of turanoseTUR	Fermentation of arabinoseARA	beta-Glucuronidasebeta GUR
[Ref.: #8450]	5677	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	+	-	-	+	-	-	+	-	+	-	-
[Ref.: #8450]	5337	+	+	+/-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+	-	-	+	-	+/-	-	-
[Ref.: #8450]	5338	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	+	-	-	+	-	+/-	+	-	-	-	-
[Ref.: #8450]	5339	+	+	-	-	+	+	+	+	+	-	-	-	-	+	+	-	-	-	+/-	-	+	+	-	+	-	-
[Ref.: #8450]	5340	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	+	-	-	+	-	-	+	-	+	-	-
[Ref.: #8450]	5341	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	+	-	-	+	-	+/-	+	-	-	-	-
[Ref.: #8450]	5342	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	+	-	-	+	-	+	+	-	+	-	-
[Ref.: #8450]	5582	+	+	-	-	+	+	+	+	+	-	-	-	-	-	+	+	-	-	-	-	-	+	-	+/-	-	-
[Ref.: #8450]	5610	+	+	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+	-	-	+	-	+	-	-
[Ref.: #8450]	5336	+	+	-	-	+	+	+	+	+	-	-	-	-	-	not determinedn.d.	+	-	-	+	-	+	+	+	+	-	-

API® STA:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	Acid from D-glucoseGLU	Acid from D-fructoseFRU	Acid from D-mannoseMNE	Acid from maltoseMAL	Acid from lactoseLAC	Acid from trehaloseTRE	Acid from D-mannitolMAN	Acid from xylitolXLT	Acid from melibioseMEL	Reduction of nitrateNIT	Alkaline phosphatasePAL	Acetoin production (Voges Proskauer test)VP	Acid from raffinoseRAF	Acid from D-xyloseXYL	Acid from sucroseSAC	Acid from methyl-alpha-D-glucopyranosideMDG	Acid from N-acetyl-glucosamineNAG	Arginine dihydrolaseADH	Urease/urea hydrolysisURE	Resistance to lysostaphin (EC 3.4.24.75)LSTR
[Ref.: #8450]	234	-	+	+	+	+	+	-	-	-	-	+	+	+	-	-	+	-	+/-	+	+	not determinedn.d.

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #8450]	Sample type/isolated from	nose

[Ref.: #67770]	Sample type/isolated from	Nose
* marker position based on {}

Isolation sources categories

#Host Body-Site

#Organ

#Nose

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence LN681574 (>99% sequence identity) for Staphylococcus from Microbeatlas

Aquatic Samples	284
Soil Samples	44
Animal Samples	8287
Plant Samples	18
Total Samples	8633

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #8450]	Pathogenicity (human)	yes
[Ref.: #8450]	Pathogenicity (animal)	yes
[Ref.: #8450]	Biosafety level	2	Risk group (German classification) According to TRBA 466

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #8450]	Staphylococcus epidermidis partial 16S rRNA gene, type strain DSM 20044T	LN681574	1503	ENA	1282 tax ID
[Ref.: #8450]	Staphylococcus epidermidis gene for 16S rRNA, partial sequence, strain: ATCC 14990	D83363	1475	ENA	1282 tax ID
[Ref.: #20218]	Staphylococcus epidermidis ATCC 14990 16S rRNA gene, partial sequence	U02913	397	ENA	1282 tax ID	*
[Ref.: #20218]	Staphylococcus epidermidis 16S ribosomal RNA (16S rRNA) gene	L37605	1468	ENA	1282 tax ID	*
[Ref.: #20218]	S.epidermidis gene for 16S ribosomal RNA	Z26894	771	ENA	1282 tax ID	*
[Ref.: #20218]	Staphylococcus epidermidis strain DSM 20044 16S ribosomal RNA gene, partial sequence	AY688053	464	ENA	1282 tax ID	*

Genome sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Staphylococcus epidermidis NBRC 100911 DNA, complete genome	AP019721		ENA	1282 tax ID
[Ref.: #67770]	Staphylococcus epidermidis JCM 2414 JCM 2414	GCA_001310935	contig	GenBank	1236978 tax ID
[Ref.: #67770]	Staphylococcus epidermidis NCTC 11047	GCA_002901875	scaffold	GenBank	1282 tax ID
[Ref.: #67770]	Staphylococcus epidermidis strain ATCC 14990 chromosome, complete genome	CP035288		ENA	1282 tax ID
[Ref.: #67770]	Staphylococcus epidermidis ATCC 14990	GCA_002087975	scaffold	GenBank	1282 tax ID
[Ref.: #67770]	Staphylococcus epidermidis NCTC11047	GCA_900458605	contig	GenBank	1282 tax ID

[Ref.: #8450]	GC-content	34.6 mol%
[Ref.: #67770]	GC-content	33.5 mol%	thermal denaturation, midpoint method (Tm)

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Staphylococcus epidermidis ATCC 14990 NCBI: GCA_006094375.1
[Ref.: #69480]	anaerobic	no	99.333	no
[Ref.: #69480]	spore-forming	no	99.392	yes
[Ref.: #69480]	gram-positive	yes	100	yes
[Ref.: #69480]	thermophile	no	98.06	no
[Ref.: #69480]	motile	no	75.003	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Staphylococcus epidermidis ATCC 14990 NCBI: GCA_006094375.1
[Ref.: #69481]	spore-forming	no	97	no

Availability in culture collections External links

[Ref.: #8450]

Culture collection no.

DSM 20044, ATCC 14990, CCM 2124, WDCM 00132, JCM 2414, CCUG 18000, CCUG 39508, CECT 232, CIP 81.55, IAM 12013, LMG 10474, NBRC 100865, NBRC 100911, NCIMB 12721, NCTC 11047

[Ref.: #20218]

Associated Passport(s) in StrainInfo

21835, 21833, 21834, 866253

Literature:

Only first 10 entries are displayed. Click here to see all.

	Title	Authors	Journal	DOI	Year
Pathogenicity	Do pneumatic tube transport systems transmit potential pathogens? A hygienic risk assessment in a university hospital.	Khaznadar L, Dancer SJ, Petersmann A, Seifert U, Below H, Papke R, Suchomel M, Kohlmann T, Kramer A	J Hosp Infect	10.1016/j.jhin.2019.11.009	2019	*
Pathogenicity	Antimicrobial activity of spices essential oils and its effectiveness on mature biofilms of human pathogens.	Condo C, Anacarso I, Sabia C, Iseppi R, Anfelli I, Forti L, de Niederhausern S, Bondi M, Messi P	Nat Prod Res	10.1080/14786419.2018.1490904	2018	*
Enzymology	Antibacterial compounds from the Australian native plant Eremophila glabra.	Algreiby AA, Hammer KA, Durmic Z, Vercoe P, Flematti GR	Fitoterapia	10.1016/j.fitote.2017.11.008	2017	*
Genetics	Draft Genome Sequence of Staphylococcus epidermidis (Winslow and Winslow) Evans (ATCC 14990).	Putonti C, Kalesinskas L, Cudone E, Engelbrecht KC, Koenig DW, Wolfe AJ	Genome Announc	10.1128/genomeA.00619-17	2017	*
Pathogenicity	Synthesis of Biscoumarin and Dihydropyran Derivatives and Evaluation of Their Antibacterial Activity.	Li J, Lv CW, Li XJ, Qu D, Hou Z, Jia M, Luo XX, Li X, Li MK	Molecules	10.3390/molecules200917469	2015	*
Pathogenicity	Antimicrobial Analysis of an Antiseptic Made from Ethanol Crude Extracts of P. granatum and E. uniflora in Wistar Rats against Staphylococcus aureus and Staphylococcus epidermidis.	Bernardo TH, Sales Santos Verissimo RC, Alvino V, Silva Araujo MG, Evangelista Pires dos Santos RF, Mauricio Viana MD, de Assis Bastos ML, Alexandre-Moreira MS, de Araujo-Junior JX	ScientificWorldJournal	10.1155/2015/751791	2015	*
Pathogenicity	[Investigation of antimicrobial and antibiofilm effects of some preservatives used in drugs, cosmetics and food products].	Guven N, Kaynak Onurdag F	Mikrobiyol Bul		2014	*
Pathogenicity	Mineralogical variables that control the antibacterial effectiveness of a natural clay deposit.	Morrison KD, Underwood JC, Metge DW, Eberl DD, Williams LB	Environ Geochem Health	10.1007/s10653-013-9585-0	2013	*
Pathogenicity	Antimicrobial activities of Aerva javanica and Paeonia emodi plants.	Mufti FU, Ullah H, Bangash A, Khan N, Hussain S, Ullah F, Jamil M, Jabeen M	Pak J Pharm Sci		2012	*
Pathogenicity	Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs.	Zhou Y, Hou Z, Fang C, Xue X, Da F, Wang Y, Bai H, Luo X	Folia Microbiol (Praha)	10.1007/s12223-012-0168-8	2012	*
Pathogenicity	In vitro study of antibacterial activity of the alga Sargassum oligocystum from the Persian Gulf.	Tajbakhsh S, Pouyan M, Zandi K, Bahramian P, Sartavi K, Fouladvand M, Asayesh G, Barazesh A	Eur Rev Med Pharmacol Sci		2011	*
Pathogenicity	Titania-silver and alumina-silver composite nanoparticles: novel, versatile synthesis, reaction mechanism and potential antimicrobial application.	Bala T, Armstrong G, Laffir F, Thornton R	J Colloid Interface Sci	10.1016/j.jcis.2011.01.044	2011	*
Pathogenicity	Towards long-lasting antibacterial stainless steel surfaces by combining double glow plasma silvering with active screen plasma nitriding.	Dong Y, Li X, Tian L, Bell T, Sammons RL, Dong H	Acta Biomater	10.1016/j.actbio.2010.08.009	2010	*
Pathogenicity	New 6-amino-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazin-6-ones: synthesis, characterization and antibacterial activity evaluation.	Almajan GL, Barbuceanu SF, Saramet I, Draghici C	Eur J Med Chem	10.1016/j.ejmech.2010.02.057	2010	*
Metabolism	The terminal A domain of the fibrillar accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes.	Macintosh RL, Brittan JL, Bhattacharya R, Jenkinson HF, Derrick J, Upton M, Handley PS	J Bacteriol	10.1128/JB.00764-09	2009	*
Pathogenicity	Synthesis, characterization and evaluation of antibacterial activity of some thiazolo[3,2-b][1,2,4]triazole incorporating diphenylsulfone moieties.	Barbuceanu SF, Almajan GL, Saramet I, Draghici C, Tarcomnicu AI, Bancescu G	Eur J Med Chem	10.1016/j.ejmech.2009.06.021	2009	*
Pathogenicity	Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60.	Angelusiu MV, Almajan GL, Rosu T, Negoiu M, Almajan ER, Roy J	Eur J Med Chem	10.1016/j.ejmech.2009.03.016	2009	*
Pathogenicity	Synthesis, characterization and antibacterial activity of some triazole Mannich bases carrying diphenylsulfone moieties.	Almajan GL, Barbuceanu SF, Almajan ER, Draghici C, Saramet G	Eur J Med Chem	10.1016/j.ejmech.2008.07.003	2008	*
Pathogenicity	Proinflammatory impact of Staphylococcus epidermidis on the nasal epithelium quantified by IL-8 and GRO-alpha responses in primary human nasal epithelial cells.	Sachse F, von Eiff C, Becker K, Steinhoff M, Rudack C	Int Arch Allergy Immunol	10.1159/000107463	2007	*
Metabolism	Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein.	Banner MA, Cunniffe JG, Macintosh RL, Foster TJ, Rohde H, Mack D, Hoyes E, Derrick J, Upton M, Handley PS	J Bacteriol	10.1128/JB.00952-06	2007	*
Metabolism	Rapid decrease of free vancomycin in dense staphylococcal cultures.	Ekdahl C, Hanberger H, Hallgren A, Nilsson M, Svensson E, Nilsson LE	Eur J Clin Microbiol Infect Dis	10.1007/s10096-005-0011-0	2005	*
Enzymology	Characterization and molecular cloning of a glutamyl endopeptidase from Staphylococcus epidermidis.	Ohara-Nemoto Y, Ikeda Y, Kobayashi M, Sasaki M, Tajika S, Kimura S	Microb Pathog	10.1006/mpat.2002.0515	2002	*
Pathogenicity	Elucidation of antibiotic effectiveness against Staphylococcus epidermidis during intraocular lens implantation.	Kadry AA, Tawfik AF, Abu El-Asrar AA, Shibl AM	Int J Antimicrob Agents	10.1016/s0924-8579(01)00338-7	2001	*
Enzymology	Identification of a novel antigen from Staphylococcus epidermidis.	Lang S, Livesley MA, Lambert PA, Littler WA, Elliott TS	FEMS Immunol Med Microbiol	10.1111/j.1574-695X.2000.tb01525.x	2000	*
Enzymology	Molecular analysis of the tagF gene, encoding CDP-Glycerol:Poly(glycerophosphate) glycerophosphotransferase of Staphylococcus epidermidis ATCC 14990.	Fitzgerald SN, Foster TJ	J Bacteriol	10.1128/JB.182.4.1046-1052.2000	2000	*
Phylogeny	Identification of atypical strains of Staphylococcus epidermidis by use of molecular tools.	Riou C, Meugnier H, Bes M, Brun Y, Fiedler F, Lasne Y, Etienne J, Freney J	Res Microbiol	10.1016/S0923-2508(99)80070-9	1997	*
Enzymology	Effect of surface modifications of intraocular lenses on the adherence of Staphylococcus epidermidis.	Schmidt H, Schloricke E, Fislage R, Schulze HA, Guthoff R	Zentralbl Bakteriol	10.1016/s0934-8840(98)80159-x	1998	*
Pathogenicity	[Adherence of staphylococci of different hydrophobicity. Study of various intraocular lenses].	Schloricke E, Schmidt H, Schulze HA, Beck R, Guthoff R, Falkenhagen U	Ophthalmologe	10.1007/s003470050204	1997	*
Phylogeny	Quantification of the ease of removal of bacteria from surfaces.	Eginton PJ, Gibson H, Holah J, Handley PS, Gilbert P	J Ind Microbiol	10.1007/BF01569984	1995	*
Metabolism	Adhesion of staphylococci to polyurethane and hydrogel-coated polyurethane catheters assayed by an improved radiolabelling technique.	John SF, Hillier VF, Handley PS, Derrick MR	J Med Microbiol	10.1099/00222615-43-2-133	1995	*
Enzymology	Characterization of the gene for the chromosomal dihydrofolate reductase (DHFR) of Staphylococcus epidermidis ATCC 14990: the origin of the trimethoprim-resistant S1 DHFR from Staphylococcus aureus?	Dale GE, Broger C, Hartman PG, Langen H, Page MG, Then RL, Stuber D	J Bacteriol	10.1128/jb.177.11.2965-2970.1995	1995	*
Pathogenicity	Comparison of adherent and non-adherent staphylococci in the induction of polymorphonuclear leukocyte activation in vitro.	Riber U, Espersen F, Kharazmi A	APMIS	10.1111/j.1699-0463.1995.tb01130.x	1995	*
Metabolism	Staphylococcus aureus but not Staphylococcus epidermidis can acquire iron from transferrin.	Lindsay JA, Riley TV, Mee BJ	Microbiology (Reading)	10.1099/00221287-141-1-197	1995	*
Pathogenicity	Induction of oxidative burst response in human neutrophils by adherent staphylococci. Comparison between Staphylococcus epidermidis and Staphylococcus aureus.	Riber U, Espersen F, Skinhoj P, Kharazmi A	APMIS	10.1111/j.1699-0463.1993.tb00081.x	1993	*
Pathogenicity	[Antibacterial activity of local anesthetics].	Noda H, Saionji K, Miyazaki T	Masui		1990	*
Pathogenicity	Nisin inhibits several gram-positive, mastitis-causing pathogens.	Broadbent JR, Chou YC, Gillies K, Kondo JK	J Dairy Sci	10.3168/jds.S0022-0302(89)79496-0	1989	*
Pathogenicity	Azelaic acid: its uptake and mode of action in Staphylococcus epidermidis NCTC 11047.	Bojar RA, Holland KT, Leeming JP, Cunliffe WJ	J Appl Bacteriol	10.1111/j.1365-2672.1988.tb02441.x	1988	*
Pathogenicity	Enzyme-linked immunosorbent assay for detection of Staphylococcus epidermidis antibody in experimental S. epidermidis endocarditis.	Espersen F, Wheat LJ, Bemis AT, White A	J Clin Microbiol	10.1128/jcm.23.2.339-342.1986	1986	*
Phylogeny	Secondary structure and phylogeny of Staphylococcus and Micrococcus 5S rRNAs.	Dekio S, Yamasaki R, Jidoi J, Hori H, Osawa S	J Bacteriol	10.1128/jb.159.1.233-237.1984	1984	*
Pathogenicity	[Verification of the effectiveness of neutralization in the in vivo study of antiseptics].	Reverdy ME, Martra A, Fleurette J	Pathol Biol (Paris)		1984	*
Cultivation	Colony-formation of staphylococci in fibronectin-soft-agar.	Lammler C, Blobel H	Zentralbl Bakteriol Mikrobiol Hyg A		1984	*
Enzymology	Purification and properties of a fructose-1,6-diphosphate activated L-lactate dehydrogenase from Staphylococcus epidermidis.	Gotz F, Schleifer KH	Arch Microbiol	10.1007/BF00447150	1975	*
Pathogenicity	Granulocyte colony-stimulating factor for the treatment of biomaterial-associated staphylococcal infections in-vitro.	Schlobe A, Schnitzler N, Schweizer K, Rohde D	Urol Res	10.1007/s00240-002-0289-7	2002	*
Pathogenicity	Monoclonal antibodies effectively potentiate complement activation and phagocytosis of Staphylococcus epidermidis in neonatal human plasma.	de Vor L, Beudeker CR, Flier A, Scheepmaker LM, Aerts PC, Vijlbrief DC, Bekker MN, Beurskens FJ, van Kessel KPM, de Haas CJC, Rooijakkers SHM, van der Flier M	Front Immunol	10.3389/fimmu.2022.933251	2022	*
	Promising Endophytic Alternaria alternata from Leaves of Ziziphus spina-christi: Phytochemical Analyses, Antimicrobial and Antioxidant Activities.	Elghaffar RYA, Amin BH, Hashem AH, Sehim AE	Appl Biochem Biotechnol	10.1007/s12010-022-03959-9	2022	*
	Biosynthesis of Smaller-Sized Platinum Nanoparticles Using the Leaf Extract of Combretum erythrophyllum and Its Antibacterial Activities.	Fanoro OT, Parani S, Maluleke R, Lebepe TC, Varghese RJ, Mgedle N, Mavumengwana V, Oluwafemi OS	Antibiotics (Basel)	10.3390/antibiotics10111275	2021	*
	Facile Green, Room-Temperature Synthesis of Gold Nanoparticles Using Combretum erythrophyllum Leaf Extract: Antibacterial and Cell Viability Studies against Normal and Cancerous Cells.	Fanoro OT, Parani S, Maluleke R, Lebepe TC, Varghese JR, Mavumengwana V, Oluwafemi OS	Antibiotics (Basel)	10.3390/antibiotics10080893	2021	*
	Inhibition of Neutrophil Functions and Antibacterial Effects of Tarragon (Artemisia dracunculus L.) Infusion-Phytochemical Characterization.	Majdan M, Kiss AK, Halasa R, Granica S, Osinska E, Czerwinska ME	Front Pharmacol	10.3389/fphar.2020.00947	2020	*
	Influence of Short Cationic Lipopeptides with Fatty Acids of Different Chain Lengths on Bacterial Biofilms Formed on Polystyrene and Hydrogel Surfaces.	Paduszynska MA, Maciejewska M, Neubauer D, Golacki K, Szymukowicz M, Bauer M, Kamysz W	Pharmaceutics	10.3390/pharmaceutics11100506	2019	*
	Synergistic effect of Carum copticum and Mentha piperita essential oils with ciprofloxacin, vancomycin, and gentamicin on Gram-negative and Gram-positive bacteria.	Talei GR, Mohammadi M, Bahmani M, Kopaei MR	Int J Pharm Investig	10.4103/jphi.JPHI_12_17	2017	*
	A New Specific DNA Target Sequence for Identification of Staphylococcus epidermidis using Modified Comparative Genomic Analysis.	Khoshbakht R, Zare H, Kamali Kakhki R, Neshani A, Arfaatabar M	Avicenna J Med Biotechnol	10.18502/ajmb.v14i3.9828	2022	*

References

#8450

Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 20044

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#22946

L. A. DEVRIESE, B. POUTREL, R. KILPPER-BÄLZ, K. H. SCHLEIFER: Staphylococcus gallinarum and Staphylococcus caprae, Two New Species from Animals. IJSEM 33: 480 - 486 1983 ( DOI 10.1099/00207713-33-3-480 )

#41796 ; Curators of the CIP;

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68375

Automatically annotated from API ID32STA .

#68378

Automatically annotated from API STA .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Staphylococcus epidermidis in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Staphylococcus epidermidis ATCC 14990

Staphylococcus epidermidis ATCC 14990

Change proposal

Change proposal